Zinc ligand-disrupted recombinant human Endostatin: Potent inhibition of tumor growth, safety and pharmacokinetic profile

Author： Sim B.K.L.  

Publisher： Springer Publishing Company

ISSN： 0969-6970

Source： Angiogenesis, Vol.3, Iss.1, 1999-01, pp. : 41-51

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Commentary on zinc ligand-disrupted recombinant human Endostatin

By Hellmann K.  

Angiogenesis, Vol. 3, Iss. 1, 1999-01 ,pp. : 3-3

Springer Publishing Company

Access to resources Recommend Favorite

AngiostatinTM and EndostatinTM:endothelial cell-specific endogenous inhibitorsof angiogenesis and tumor growth

By Sim B.K.L.  

Angiogenesis, Vol. 2, Iss. 1, 1998-01 ,pp. : 37-48

Springer Publishing Company

Access to resources Recommend Favorite

Intravenous delivery of an endostatin gene complexed in cationic lipid inhibits systemic angiogenesis and tumor growth in murine models

By Blezinger P.  

Angiogenesis, Vol. 3, Iss. 3, 1999-01 ,pp. : 205-210

Springer Publishing Company

Access to resources Recommend Favorite

Growth Inhibition of Enteric Pathogens by Zinc Sulfate: An in vitro Study

By  

Medical Principles and Practice, Vol. 13, Iss. 5, 2004-08 ,pp. : 286-289

Karger

Access to resources Recommend Favorite

Human Studies of Recombinant Human Nerve Growth Factor and Diabetic Peripheral Neuropathy

By  

European Neurology, Vol. 41, Iss. 1, 1999-02 ,pp. : 20-26

Karger

Access to resources Recommend Favorite